

IN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi


UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half


Clinigen Chair Leaves Audit Committee After Shareholder Engagement


UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair


UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK


Diurnal Gets European Marketing Authorisation For Chronocort


UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development


Diurnal Announces GBP7 Million Placing To Fund Drug Development